{"nctId":"NCT04472611","briefTitle":"Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial","startDateStruct":{"date":"2020-10-30","type":"ACTUAL"},"conditions":["SARS-CoV-2"],"count":250,"armGroups":[{"label":"Standard of Care (SOC) and Colchicine+Rosuvastatin","type":"EXPERIMENTAL","interventionNames":["Drug: Standard of Care (SOC) and Colchicine+Rosuvastatin"]},{"label":"Standard of care (SOC)","type":"NO_INTERVENTION","interventionNames":[]}],"interventions":[{"name":"Standard of Care (SOC) and Colchicine+Rosuvastatin","otherNames":["SOC & Colchicine and Rosuvastatin"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria 1.18 years or older and confirmed SARS-CoV-2 infection by RT-PCR 2. Patient is admitted to the floor (non-ICU) within 48 hours of hospital admission 3. The patient, or legally authorized representative, has been informed of the nature of the study, agrees to its provisions and has provided witnessed (by 2 independent members of the health care team) oral informed consent, or a photograph of the signed informed consent approved by the Institutional Review Board (IRB)\n\nExclusion Criteria:\n\n1. Known pregnancy or nursing mothers\n2. Known allergy to statins or colchicine\n3. Patient is on chronic colchicine or oral corticosteroid treatment\n4. Acute liver disease defined by elevated transaminases (AST/ALT \\> 3x ULN)\n5. Severe chronic kidney disease defined as glomerular filtration rate (GFR) \\< 30mL/min1.73 m2\n6. Severe QTc prolongation (\\>500ms narrow QRS\\<120ms and \\>550ms for wide QRS\\>120)\n7. Presents with severe disease on admission (WHO ordinal scale of clinical improvement scores 5-8)\n8. Rhabdomyolysis or CPK \\> 5x ULN\n9. Thrombocytopenia defined as platelet count \\< 50,000 / mm3\n10. Leukopenia defined as white blood cell count \\< 3000 ml\n11. Severe anemia defined as Hemoglobin value \\<8 g/100ml\n12. Participation in any other clinical trial of an experimental treatment for COVID-19","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With COVID 19 Severity","description":"As defined by World Health Organization Ordinal Scale, which ranges from 1 to 8. Severity of COVID measured by WHO Scores 5-8: Defined as 5= Hospitalized requiring including CPAP, face mask, high flow nasal cannula (Excludes regular nasal cannula), 6= Hospitalized requiring intubation and mechanical ventilation, 7= Hospitalized requiring mechanical ventilation and additional organ support (vasopressors, renal replacement therapy, ECMO), 8= Death. Data presented is for Max WHO scores 5-8, indicating moderately to severely infected participants.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"4","spread":null}]},{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":125},"commonTop":["Increased Liver Function Tests","Gastrointestinal Distress"]}}}